Paraoxonase 1 gene and glutathione S-transferase μ 1 gene interaction with preterm delivery in Korean women

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 6, 2010, Pages 569.e1-569.e7

  Lee, Bo Eun ^a   Park, Hyesook ^a   Park, Eun Ae ^a   Gwak, Hyesun ^b   Ha, Eun Hee ^a   Pang, Myung Geol ^c   Kim, Young Ju ^a  

^a Ewha Womans University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

Gene gene interaction; Glutathione S transferase 1; Paraoxonase; Preterm delivery

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; ARYLDIALKYLPHOSPHATASE; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN INTERACTION; RISK ASSESSMENT; ULTRAVIOLET SPECTROPHOTOMETRY; ASIAN; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ETHNOLOGY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GESTATIONAL AGE; MULTIVARIATE ANALYSIS; PREGNANCY; PREMATURITY; REFERENCE VALUE; RISK; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; ARYLDIALKYLPHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GESTATIONAL AGE; GLUTATHIONE TRANSFERASE; HUMANS; KOREA; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, GENETIC; PREGNANCY; PREMATURE BIRTH; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 79952114934     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.07.029     Document Type: Article

References (32)

1. Koo YH, Kim SK, Shim JY, Won HS, Lee PR, Kim A. Analysis of preterm birth rate based on birth certification data: from 1995 to 2003. Korean J Obstet Gynecol 2006;49: 1855-65.
2. Glodenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998;339: 313-20. (Pubitemid 28366421)
3. Rush RW, Keirse MJ, Howat P, Baum JD, Anderson AB, Turnbull AC. Contribution of preterm delivery to perinatal mortality. Br Med J 1976;2: 965-8.
4. Goldenberg RL, Andrews WW. Intrauterine infection and why preterm prevention programs have failed. Am J Public Health 1996;86: 781-3.
5. Adams MM, Elam-Evans LD, Wilson HG, Gilbertz DA. Rates and factors associated with recurrence of preterm delivery. JAMA 2000; 283: 1591-6.
6. Clausson B, Lichtenstein D, Cnattingius S. Genetic influence on birthweight and gestational length determined by studies in offspring of twins. BJOG 2000;107: 375-81. (Pubitemid 30145380)
7. Suh YJ, Kim YJ, Park H, Park EA, Ha EH. Oxidative stress-related gene interactions with preterm delivery in Korean women.AmJ Obstet Gynecol 2008;198: 541.e1-7.
8. Wang X, Zuckerman B, Pearson C, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287: 195-202. (Pubitemid 34251944)
9. Pasqualini L, Cortese C, Marchesi S, et al. Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis 2005;183: 349-54. (Pubitemid 41579288)
10. Min J, Park H, Park B, et al. Paraoxonase gene polymorphism and vitamin levels during pregnancy: relationship with maternal oxidative stress and neonatal birth weight. Reprod Toxicol 2006;22: 418-24. (Pubitemid 44344442)
11. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/ arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispo 1991;19: 100-6.
12. Toy H, Camuzcuoglu H, Celik H, Erel O, Aksoy N. Assessment of serum paraoxonase and arylesterase activities in early pregnancy failure. Swiss Med Wkly 2009;139: 76-81.
13. Uzun H, Benian A, Madazli R, Topcuoglu MA, Aydin S, Albayrak M. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest 2005;60: 195-200. (Pubitemid 41551970)
14. Chen D, Hu Y, Chen C, et al. Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology 2004;15: 466-70. (Pubitemid 40416935)
15. Lawlor DA, Gaunt TR, Hinks LJ, et al. The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British women's heart and health cohort study. Paediatric Perinat Epidemiol2006;20: 244-50.
16. Humbert R, Adler DA, Disteche CM, et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993;3: 73-6. (Pubitemid 23063292)
17. Sampson MJ, Braschi S, Willis G, Astley SB. Paraoxonase-I (PON-I) genotype and activity and in vivo oxidized plasma low-density lipoprotein in type II diabetes. Clin Sci 2005; 109: 189-97. (Pubitemid 41117303)
18. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals highorder interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69: 138-47. (Pubitemid 32614026)
19. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003;19: 376-82. (Pubitemid 36284937)
20. Moore JH, Gilbert JC, Tsai CT, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006; 241: 252-61. (Pubitemid 43993963)
21. Bhattacharyya T, Nicholls SJ, Topol EJ, et al. Relationship of paraoxonase 1 gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008;299: 1265-76. (Pubitemid 351439073)
22. Leung TY, Leung TN, Sahota DS, et al. Trends in maternal obesity and associated risks of adverse pregnancy outcomes in a population of Chinese women. BJOG 2008;115: 1529-37.
23. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998;338: 147-52. (Pubitemid 28041861)
24. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003; 88: 2393-8. (Pubitemid 36724402)
25. Catov JM, Bodnar LM, Kip KE, et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol 2007;197: 610.e1-7.
26. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial functionand markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007;92: 969-75. (Pubitemid 46465671)
27. Woods JR, Plessinger MA, Miller RK. Vitamins C and E: missing links in preventing preterm premature rupture of membranes? Am J Obstet Gynecol 2001;185: 5-10. (Pubitemid 32681784)
28. Iams JD. Prediction and early detection of preterm labor. Obstet Gynecol 2003;101: 402-12. (Pubitemid 36170144)
29. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87: 4231-7.
30. Binkova B, Chvatalova I, Lnenickova Z, et al. PAH-DNA adducts in environmentally expressed population in relation to metabolic and DNA repair gene polymorphisms. Mutat Res 2007;620: 49-61. (Pubitemid 46776723)
31. Menon R, Velez DR, Simhan H, et al. Multilocus interactions at maternal tumor necrosis factor-alpha, tumor necrosis factor receptors, interleukin-6 and interleukin-6 receptor genes predict spontaneous preterm labor in European-American women. Am J Obstet Gynecol 2006;194: 1616-24.
32. Kumru S, Aydin S, Gursu MF, Ozcan Z. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and aryesterase activities in severe preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2004;114: 177-81. (Pubitemid 38622079)